Michael Beaty to Protein Kinase Inhibitors
This is a "connection" page, showing publications Michael Beaty has written about Protein Kinase Inhibitors.
Connection Strength
0.130
-
Wang W, Cortes JE, Lin P, Beaty MW, Ai D, Amin HM, McDonnell TJ, Ok CY, Kantarjian HM, Medeiros LJ, Hu S. Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors. Blood. 2015 Oct 01; 126(14):1699-706.
Score: 0.130